Navigation Links
UMass Consortium awarded $300,000 from Juvenile Diabetes Research Foundation and Iacocca Foundation
Date:11/1/2007

WORCESTER, Mass.Investigators from the University of Massachusetts Medical School (UMMS) will investigate the causes of type 1 diabetes with dual grants from the Juvenile Diabetes Research Foundation (JDRF) and The Iacocca Foundation. The grants, of $150,000 each, will support the research efforts of the UMMS Heat Shock Protein Consortium. Directed by Aldo A. Rossini, MD, the William and Doris Krupp Professor of Medicine and professor of medicine and molecular medicine, the Heat Shock Protein Consortium brings together a unique group of scientists with diverse expertise in the basic sciences.

The innovation and synergy of the Consortium has already provided a mechanism for interaction and productivity in the field of science, explained Dr. Rossini. This synergy, we believe, will permit a new area of discovery by bringing together viewpoints of basic cell biology that are now focusing on the understanding of the pathogenesis of type 1 diabetes.

Heat shock proteins (Hsp) are essential proteins that protect the cell from a wide variety of environmental stresses. However, recent studies have demonstrated that altered Hsp function is associated with the development of a number of diseases, including type 1 diabetes. This funding will provide support for a number of innovative studies across a variety of departments and disciplines that aim to understand the Hsp abnormalities that may lead to the development and progression of type 1 diabetes.

We are committed to supporting young investigators in their development into diabetes-related careers and this important funding will foster creative approaches to the question of the role of cellular stress and autoimmune diabetes, explained Consortium investigator Dale L. Greiner, PhD, professor of medicine.

Better understanding the pathogenesis of diabetes will help accelerate the pace of science leading to cures and treatments for type 1 diabetes and its complications across a range of research areas, said Richard A. Insel, MD, Executive Vice President for Research at JDRF. Were thrilled to be partnering with The Iacocca Foundation to fund this important science at the University of Massachusetts Medical School.

Specific laboratories and their respective projects supported by the grants include:

  • Rita Bortell, PhD, associate professor of medicineThe role of endoplasmic reticulum (ER) stress in immune cell functions and during pathogenesis of autoimmune diabetes
  • Stephen J. Doxsey, PhD, professor of molecular medicine, biochemistry & molecular pharmacology and cell biologyThe novel role of centrosome proteins in insulin secretion and cellular stress
  • Dale L. Greiner, PhD, professor of medicineThe role of ER stress in islet transplantation
  • Gregory J. Pazour, PhD, associate professor of molecular medicineThe role of the pancreatic beta cell cilium in diabetes
  • Fumihiko Urano, MD, assistant professor of molecular medicineThe role of ER stress in autoimmune diabetes

Were excited about this partnership, said Iaccoca Foundation Executive Director Dana Ball. Our mission is to explore every possible avenue to find a cure for type 1 diabetes and we see incredible promise in the innovative approach UMass is taking.


'/>"/>

Contact: Kelly Bishop
kelly.bishop@umassmed.edu
508-856-2000
University of Massachusetts Medical School
Source:Eurekalert

Related medicine news :

1. Chancellor Of UMass Medical School Resigns Due to Health Reasons
2. NIH Funds the Development of National Consortium of Universities
3. Autism Gene Identified by Yale and Global Consortium
4. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
5. Scientists Awarded Appropriately For Contribution Towards Medical Research
6. Lifespan And Height Interlinked With Juvenile Diseases.
7. Psychiatric disorders among juveniles
8. Migraine & Juvenile stroke could be associated
9. Guidelines for treatment of juvenile idiopathic arthritis formulated
10. Type I diabetes or juvenile diabetes delays kidney disease onset
11. A New Technique For Treating Juvenile Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2017)... CANADA (PRWEB) , ... July 22, 2017 , ... ... offer patients with irreparable rotator cuff repairs the opportunity to return to sports ... the American Orthopaedic Society for Sports Medicine’s Annual Meeting in Toronto, ...
(Date:7/21/2017)... ... ... The Ellis Agency, an eastern Georgie provider of insurance management and financial ... event with the goal of bringing in support for epilepsy patients in the greater ... recently launched a charity campaign of her own by donating her birthday to the ...
(Date:7/21/2017)... Long Grove, Ill. (PRWEB) , ... July 21, 2017 , ... ... Air & Fabric Liquid eco-friendly odor-control solution for colleges and universities at the ... to safely and effectively eliminate severe cannabis and tobacco smoke odors without the use ...
(Date:7/21/2017)... (PRWEB) , ... July 21, 2017 , ... The Margarian ... falsely advertising the contents of its ginger ale for allegedly containing no ginger. Dr. ... Dr. Pepper Snapple Group, Inc., plaintiff Gegham Margaryan alleges Canada Dry Ginger Ale claims ...
(Date:7/21/2017)... ... July 21, 2017 , ... “Kids aren't born knowing ... tie their shoes,” says Suzanne Tucker, Founder of St. Louis-based positive education company Generation ... launches on Kickstarter on Monday, July 21st. , The kit uses colorful, engaging ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)... July 13, 2017  New York City-based market research firm ... should be aware of.  From new products to new costs, ... in a recently completed study, Potential Pipeline Disruptors . ... 1.  Age-Driven Growth - True Impact ... aware of the impact the growing population and, to a ...
(Date:7/11/2017)... , July 11, 2017  The global market ... revenues of approximately $394.1 million in 2016.  Although in ... of solid growth, in particular as a result of ... practice, and the recent introduction of a significant number ... for less-invasive testing of tumor biomarkers to guide treatment ...
(Date:7/10/2017)... Md. , July 10, 2017 The ... non-animal test methods, is the recipient of a VITROCELL® ... the PETA International Science Consortium. The device, which is ... used to expose human lung cells to airborne test ... IIVS will use the VITROCELL® system for testing combustible ...
Breaking Medicine Technology: